Post-approval studies (Phase 4)UnknownNCT01830257
What this trial is testing
Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)
Who this might be right for
Adverse Reaction to Drug
Beijing Center for Disease Control and Prevention 1,000